ORGO
Price
$3.95
Change
-$0.01 (-0.25%)
Updated
Oct 13 closing price
Capitalization
501.09M
23 days until earnings call
PRGO
Price
$21.19
Change
-$0.06 (-0.28%)
Updated
Oct 13 closing price
Capitalization
2.92B
22 days until earnings call
Interact to see
Advertisement

ORGO vs PRGO

Header iconORGO vs PRGO Comparison
Open Charts ORGO vs PRGOBanner chart's image
Organogenesis Holdings
Price$3.95
Change-$0.01 (-0.25%)
Volume$287.82K
Capitalization501.09M
Perrigo
Price$21.19
Change-$0.06 (-0.28%)
Volume$1.53M
Capitalization2.92B
ORGO vs PRGO Comparison Chart in %
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ORGO vs. PRGO commentary
Oct 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORGO is a StrongBuy and PRGO is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 14, 2025
Stock price -- (ORGO: $3.95 vs. PRGO: $21.19)
Brand notoriety: ORGO and PRGO are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ORGO: 37% vs. PRGO: 89%
Market capitalization -- ORGO: $501.09M vs. PRGO: $2.92B
ORGO [@Pharmaceuticals: Generic] is valued at $501.09M. PRGO’s [@Pharmaceuticals: Generic] market capitalization is $2.92B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORGO’s FA Score shows that 1 FA rating(s) are green whilePRGO’s FA Score has 2 green FA rating(s).

  • ORGO’s FA Score: 1 green, 4 red.
  • PRGO’s FA Score: 2 green, 3 red.
According to our system of comparison, PRGO is a better buy in the long-term than ORGO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORGO’s TA Score shows that 4 TA indicator(s) are bullish while PRGO’s TA Score has 4 bullish TA indicator(s).

  • ORGO’s TA Score: 4 bullish, 6 bearish.
  • PRGO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PRGO is a better buy in the short-term than ORGO.

Price Growth

ORGO (@Pharmaceuticals: Generic) experienced а -5.95% price change this week, while PRGO (@Pharmaceuticals: Generic) price change was -3.90% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.92%. For the same industry, the average monthly price growth was +2.12%, and the average quarterly price growth was +55.66%.

Reported Earning Dates

ORGO is expected to report earnings on Nov 06, 2025.

PRGO is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.92% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRGO($2.92B) has a higher market cap than ORGO($501M). PRGO has higher P/E ratio than ORGO: PRGO (2818.00) vs ORGO (63.75). ORGO YTD gains are higher at: 23.438 vs. PRGO (-14.799). PRGO has higher annual earnings (EBITDA): 612M vs. ORGO (3.19M). PRGO has more cash in the bank: 454M vs. ORGO (73.1M). ORGO has less debt than PRGO: ORGO (40.8M) vs PRGO (3.65B). PRGO has higher revenues than ORGO: PRGO (4.33B) vs ORGO (429M).
ORGOPRGOORGO / PRGO
Capitalization501M2.92B17%
EBITDA3.19M612M1%
Gain YTD23.438-14.799-158%
P/E Ratio63.752818.002%
Revenue429M4.33B10%
Total Cash73.1M454M16%
Total Debt40.8M3.65B1%
FUNDAMENTALS RATINGS
ORGO vs PRGO: Fundamental Ratings
ORGO
PRGO
OUTLOOK RATING
1..100
715
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
33
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9592
PRICE GROWTH RATING
1..100
6280
P/E GROWTH RATING
1..100
92
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRGO's Valuation (33) in the Pharmaceuticals Other industry is somewhat better than the same rating for ORGO (74) in the Financial Conglomerates industry. This means that PRGO’s stock grew somewhat faster than ORGO’s over the last 12 months.

PRGO's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as ORGO (100) in the Financial Conglomerates industry. This means that PRGO’s stock grew similarly to ORGO’s over the last 12 months.

PRGO's SMR Rating (92) in the Pharmaceuticals Other industry is in the same range as ORGO (95) in the Financial Conglomerates industry. This means that PRGO’s stock grew similarly to ORGO’s over the last 12 months.

ORGO's Price Growth Rating (62) in the Financial Conglomerates industry is in the same range as PRGO (80) in the Pharmaceuticals Other industry. This means that ORGO’s stock grew similarly to PRGO’s over the last 12 months.

PRGO's P/E Growth Rating (2) in the Pharmaceuticals Other industry is in the same range as ORGO (9) in the Financial Conglomerates industry. This means that PRGO’s stock grew similarly to ORGO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ORGOPRGO
RSI
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
74%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
69%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
72%
MACD
ODDS (%)
Bearish Trend 6 days ago
88%
Bullish Trend 1 day ago
64%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
66%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
62%
Advances
ODDS (%)
Bullish Trend 20 days ago
80%
Bullish Trend 13 days ago
61%
Declines
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
66%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 6 days ago
70%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
50%
View a ticker or compare two or three
Interact to see
Advertisement
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GQGRX17.32N/A
N/A
GQG Partners Emerging Markets Equity R6
LSSCX22.34N/A
N/A
Loomis Sayles Small Cap Value Instl
TEMWX19.10N/A
N/A
Templeton World A
HFDTX19.39N/A
N/A
Hartford Schroders US MidCap Opps R5
NEXIX35.55N/A
N/A
Shelton Sustainable Equity Institutional

ORGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORGO has been loosely correlated with ANIP. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ORGO jumps, then ANIP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORGO
1D Price
Change %
ORGO100%
-0.25%
ANIP - ORGO
49%
Loosely correlated
-1.31%
PRGO - ORGO
45%
Loosely correlated
-0.28%
ANIK - ORGO
32%
Poorly correlated
+0.89%
ACET - ORGO
29%
Poorly correlated
+1.25%
AMRX - ORGO
28%
Poorly correlated
-2.21%
More

PRGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRGO has been loosely correlated with EOLS. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if PRGO jumps, then EOLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRGO
1D Price
Change %
PRGO100%
-0.28%
EOLS - PRGO
46%
Loosely correlated
-2.28%
ORGO - PRGO
45%
Loosely correlated
-0.25%
AMRX - PRGO
39%
Loosely correlated
-2.21%
ZTS - PRGO
33%
Loosely correlated
+0.81%
PBH - PRGO
33%
Loosely correlated
+1.38%
More